In risk assessment, biomarkers are used to estimate the likelihood of adverse effects occurring in humans due to exposure to chemicals. Sensitive biomarkers enhance the precision of these assessments by providing data on early biological changes. This information is crucial for establishing safe exposure levels and regulatory standards.
